Weekly market opportunities in T-Advisor: the best on February 20th Market Opportunities 20 February 2019 , No hay comentarios T-Advisor updates weekly a list of market opportunities from several stocks exchanges around the world. We sum up a selection of the best ones: EUROPE Astra Zeneca (STOCKHOLMBOERSEN): AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. They focus on three main therapy areas – Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory – and are also selectively active in the areas of autoimmunity, neuroscience, and infection. AstraZeneca operates in over 100 countries and its medicines are used by millions of patients worldwide. AMERICA Ilumina Inc (NASDAQ): Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. Illumina’s based solutions focus on DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. Their customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe. ASIA-PACIFIC Leighton Holdings (AUSTRALIA STOCK EXCHANGE): World-leading infrastructure, mining, services, and public-private partnerships group. With a history since 1899, and more than 50,000 people in 20 countries is a member of the S&P/ASX 100 index, the Dow Jones Sustainability Australia Index and FTSE4Good. Also has a 45% investment in HLG Contracting, a 59.11% investment in Devine and a 47% investment in Ventia. Find more opportunities from the main exchanges in the world on our module “Market opportunities” in T-Advisor.